Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Biomarker Discovery Outsourcing Services Industry By 2029?

In recent times, there has been a quick expansion in the size of the biomarker discovery outsourcing services market. It is projected to climb from $14.58 billion in 2024 to $16.96 billion in 2025, with a compound annual growth rate (CAGR) of 16.3%. The robust growth during the past years can be linked to factors such as the mounting burden of diseases, demand in pharmaceutical research & development, regulatory circumstances, budget-friendly solutions, partnerships in research, and the influence of globalization.

Going forward, we anticipate a significant increase in the size of the biomarker discovery outsourcing services market. The market value will go up to $30.13 billion by 2029, indicating a compound annual growth rate (CAGR) of 15.4%. This anticipated growth during the forthcoming years can be associated with several factors including the advancement of personalized medicine, integration of AI and machine learning, expansion in precision oncology, biomarker validation services, regulatory support, increasing demand for targeted therapies, and a shift towards patient-oriented healthcare. Noteworthy trends during this projection period encompass heightened endorsement of precision medicine, technological progress, a surge in demand for companion diagnostics, widening of drug development pipelines, emerging use cases in non-traditional disease sectors, incorporation of AI and ML, regulation assistance and standardization, expansion on a global scale, partnerships and alliances, with a spotlight on cost effectiveness and time efficiency.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15741&type=smp

Which Industry Forces Are Driving The Biomarker Discovery Outsourcing Services Market Forward?

The proliferation of personalized medicine is predicted to be a strong catalyst to the expansion of the biomarker discovery outsourcing services market in the future. Personalized medicine is a healthcare approach that adjusts medical treatments in accordance with the unique traits of each patient. The advent of personalized medicine has been instigated by individual genetic, environmental, and lifestyle factors, thereby enabling impeccable healthcare results that not only enhance patient care, but also minimize adverse reactions. Outsourcing biomarker discovery services plays a critical role in promoting personalized medicine as it offers custom diagnostic and therapeutic solutions grounded on the biological markers of each patient. For example, as per a report by the Personalized Medicine Coalition, a US-based entity, in February 2024, it was revealed that in 2023, the FDA gave approval to 16 fresh personalized treatments for rare disease patients, a significant increase from the six approved in 2022. The personalized treatments approved in 2023 encompassed seven drugs for cancer and three for other diseases and disorders. Hence, the heightened emphasis on personalized medicine contributes to the advancement of the biomarker discovery outsourcing services market.

What Is The Segment Breakdown Of The Biomarker Discovery Outsourcing Services Market?

The biomarker discovery outsourcing servicesmarket covered in this report is segmented –

1) By Type: Predictive Biomarkers; Prognostic Biomarkers; Safety Biomarkers; Surrogate Endpoints

2) By Discovery Phase: Biomarker Identification; Biomarker Validation; Biomarker Profiling; Biomarker Panel Development; Biomarker Selection

3) By Therapeutic Area: Oncology; Cardiology; Neurology; Autoimmune Diseases; Other Therapeutic Areas

4) By End Use: Pharmaceutical Companies; Biotechnology Companies

Subsegments:

1) By Predictive Biomarkers: Disease Risk Assessment; Therapy Response Prediction; Personalized Medicine Guidance

2) By Prognostic Biomarkers: Disease Progression Prediction; Patient Survival Forecast; Recurrence Risk Assessment

3) By Safety Biomarkers: Toxicity Prediction; Drug Safety Evaluation; Adverse Effect Risk Assessment

4) By Surrogate Endpoints: Clinical Trial Outcome Indicators; Disease Progression Monitoring; Therapy Efficacy Tracking

What New Opportunities Are Emerging From Trends In The Biomarker Discovery Outsourcing Services Market?

Leading businesses in the biomarker discovery outsourcing services market are concentrating on the development of multiplexed biomarker assays, like the immunoproteomic discovery platform, with the aim of enhancing patient results and propelling biomarker discovery advancements. The immunoproteomic discovery platform is a unique system that merges immunology and proteomics to identify and examine proteins integral to the immune response. For instance, in October 2023, Sengenics Corporation LLC, a precision medicine firm based in Singapore, unveiled a comprehensive protein microarray platform for studying autoantibodies related to disease diagnosis and therapeutic intervention. The i-Ome Discovery platform was created to foster immune biomarker exploration and development, aiding academic and clinical biopharmaceutical research teams in gaining better comprehension of the intricate interplay and associations between proteins, the immune system and disease.

Which Companies Are Contributing Significantly To The Biomarker Discovery Outsourcing Services Market Growth?

Major companies operating in the biomarker discovery outsourcing services market are Thermo Fisher Scientific Inc., Labcorp Drug Development Inc., ICON plc, Eurofins Scientific SE, WuXi AppTec Co. Ltd., Syneos Health Inc., Intertek Group plc, Charles River Laboratories International Inc., Parexel International Corporation, QIAGEN N.V., Medpace Inc., Bioclinica Inc., Evotec SE, GenScript Biotech Corporation, Precision for Medicine Inc., BioAgilytix Labs LLC, Celerion Inc., Frontage Laboratories Inc., SomaLogic Inc., Selvita S.A., BioIVT LLC, Discovery Life Sciences LLC, Metabolon Inc., Caprion Proteomics Inc., Canopy Biosciences LLC, Crown Bioscience Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/biomarker-discovery-outsourcing-services-global-market-report

Which Region Is Leading Innovation In The Biomarker Discovery Outsourcing Services Market?

North America was the largest region in the biomarker discovery outsourcing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker discovery outsourcing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15741&type=smp

Browse Through More Reports Similar to the Global Biomarker Discovery Outsourcing Services Market 2025, By The Business Research Company

Biolubricants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biolubricants-global-market-report

Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Biofertilizers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biofertilizers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model